Involvement of organic molybdenum compounds in the interaction between copper, molybdenum, and sulfur.
The effect on Cu metabolism of two organic Mo compounds, cysteine-Mo (CM) and cysteine-Mo-S (CMS), and of an inorganic compound, tetrathiomolybdate (TTM), was investigated in sheep. Intravenous administration of CMS or TTM increased total plasma Cu concentrations and promoted the appearance of trichloroacetic acid (TCA)-insoluble Cu in plasma. Plasma Mo was increased by both compounds. Column chromatography of plasma showed that CMS caused the accumulation of TCA-insoluble Cu in high-MW fractions, whereas TTM increased the Cu content of low-MW fractions, mainly albumin. CMS and TTM increased the concentration of Cu and Mo in kidney. In liver, Mo concentrations were elevated by both CMS and TTM, and Cu concentrations were reduced by TTM when it was given at a low dose rate. The subcellular distribution of Cu and Mo in liver and kidney was investigated. The findings are discussed in relation to the proposal that Mo-containing, organic compounds are intermediaries in the interaction between Cu, Mo, and S in ruminants.
D000818:Animals; D003300:Copper / Q000097:blood / Q000378:metabolism*; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D005260:Female; D007668:Kidney / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D008297:Male; D008982:Molybdenum / Q000097:blood / Q000138:chemical synthesis / Q000378:metabolism* / Q000494:pharmacology*; D009942:Organometallic Compounds / Q000378:metabolism / Q000494:pharmacology*; D012756:Sheep; D013347:Subcellular Fractions / Q000378:metabolism; D013482:Superoxide Dismutase / Q000097:blood; D014018:Tissue Distribution
D009942:Organometallic Compounds; C049632:bis(cysteinato(2-)-N,O,S)di-mu-oxodioxodimolybdate(2-); C049631:bis(cysteinato(2-)-N,O,S)dioxodi-mu-thioxodimolybdate(2-); D003300:Copper; D008982:Molybdenum; C020809:tetrathiomolybdate; D013482:Superoxide Dismutase